More COVID-19 vaccines are coming. That’s good news since the number of cases has been soaring worldwide. Two new vaccines have caught the attention, having published their Phase 3 results last week. Johnson & Johnson has developed a single-dose Janssen vaccine, while Novavax’s jab is a two-shot dosage like all other coronavirus vaccines. Johnson & Johnson’s vaccine showed a 78 per cent efficacy rate in US trials, while the Novavax’s recorded 89.3 per cent efficacy in the UK trials. So what makes these vaccines different from the rest. Yes, Johnson & Johnson’s single jab is a telling difference, but reports say that the company is working on a double-dose vaccine to improve its efficacy. A
Hence then, the article about covid 19 the single shot janssen vaccine could be a gamechanger in the fight against the pandemic was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19: The single-shot Janssen vaccine could be a gamechanger in the fight against the pandemic )